Cheap cholera vaccine developed

An international health organisation said it has developed the world's first cheap cholera vaccine which has been licensed in India, paving the way for its global use.

The Seoul-based International Vaccine Institute (IVI) said the new product costs about one dollar per dose compared to the existing internationally licensed oral vaccine which was too expensive for developing countries - costing 18 dollars a dose in Bangladesh.

John Clemens, the institute director-general, said in a statement the licensing of the new product in India "paves the way for a wider use of the vaccine in cholera-endemic populations in Asia and elsewhere."

This was because the World Health Organisation (WHO) has approved the national regulatory authority there.

Vaccine tested, shows protection
The IVI said it modified a Vietnamese-made product to create the new vaccine, with help from the Bill and Melinda Gates Foundation and the governments of South Korea and Sweden. It said the vaccine has been tested in the slums of the Indian city of Kolkota, and initial results showed it confers significant protection.

The IVI, citing a WHO report, said cholera claimed 4 031 lives in 177 963 outbreaks in 53 countries - mostly in Africa – in 2007.

It said the actual number of deaths from cholera, given widespread under-reporting, is estimated at up to 120 000 a year.

"The use of safe and effective cholera vaccines in cholera-endemic areas could lead to a significant and rapid decline in cholera incidence and, ultimately, to its control worldwide," said Clemens.

The United Nations Development Program launched the IVI in South Korea in 1997. It is the world's only international body working exclusively on developing vaccines for the world's poorest people. – (Sapa, April 2009)

Read more:
Cholera: millions infected
Cholera timeline

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Voting Booth
The ANC's leadership race is heating up. Who do you think will be elected party president at Nasrec in December?
Please select an option Oops! Something went wrong, please try again later.
Results
Nkosazana Dlamini-Zuma has got it in the bag
7% - 718 votes
I foresee a second term for Cyril Ramaphosa
83% - 8462 votes
Don’t discount a Zweli Mkhize win
10% - 1011 votes
Vote
Rand - Dollar
17.78
-0.8%
Rand - Pound
20.13
+0.5%
Rand - Euro
17.58
+0.2%
Rand - Aus dollar
11.55
-0.8%
Rand - Yen
0.12
-0.5%
Gold
1,716.66
-0.6%
Silver
20.67
-1.9%
Palladium
2,260.50
-2.7%
Platinum
922.00
-1.2%
Brent Crude
91.80
+3.2%
Top 40
59,202
-1.1%
All Share
65,613
-1.1%
Resource 10
63,687
-1.4%
Industrial 25
79,239
-1.1%
Financial 15
13,961
-0.7%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE